Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006 ; volume:11 ; number:1 ; day:30 ; month:7 ; year:2011 ; pages:1-9 ; date:12.2011
BMC psychiatry ; 11, Heft 1 (30.7.2011), 1-9, 12.2011
- Creator
-
Nyhlén, Anna
- Contributor
-
Fridell, Mats
Bäckström, Martin
Hesse, Morten
KRANTZ, PETER
SpringerLink (Online service)
- DOI
-
10.1186/1471-244X-11-122
- URN
-
urn:nbn:de:1111-2016030431035
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nyhlén, Anna
- Fridell, Mats
- Bäckström, Martin
- Hesse, Morten
- KRANTZ, PETER
- SpringerLink (Online service)
Other Objects (12)
Some psychiatric comorbidity among patients with substance abuse disorder related to pregabalin
The co-morbidity of DSM-V Gambling with DSM-V mental disorders and substance abuse in a Kenyan context of high risk schizophrenia
Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects
Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects
Women and Substance Abuse Problems
Substance abuse and personality disorder comorbidity in adolescent outpatients: are girls more severely ill than boys?
Psychiatric morbidity, somatic comorbidity and substance use in an adolescent psychiatric population at 3-year follow-up
Family support & substance abuse during puberty
Science and policy in substance abuse
Substance abuse treatment, prevention, and policy
Randomization in substance abuse clinical trials
Substance Abuse Treatment Centers and Local Crime
Some psychiatric comorbidity among patients with substance abuse disorder related to pregabalin
The co-morbidity of DSM-V Gambling with DSM-V mental disorders and substance abuse in a Kenyan context of high risk schizophrenia
Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects
Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects
Women and Substance Abuse Problems
Substance abuse and personality disorder comorbidity in adolescent outpatients: are girls more severely ill than boys?
Psychiatric morbidity, somatic comorbidity and substance use in an adolescent psychiatric population at 3-year follow-up
Family support & substance abuse during puberty
Science and policy in substance abuse
Substance abuse treatment, prevention, and policy
Randomization in substance abuse clinical trials
Substance Abuse Treatment Centers and Local Crime
Some psychiatric comorbidity among patients with substance abuse disorder related to pregabalin
The co-morbidity of DSM-V Gambling with DSM-V mental disorders and substance abuse in a Kenyan context of high risk schizophrenia
Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects
Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects
Women and Substance Abuse Problems
Substance abuse and personality disorder comorbidity in adolescent outpatients: are girls more severely ill than boys?
Psychiatric morbidity, somatic comorbidity and substance use in an adolescent psychiatric population at 3-year follow-up
Family support & substance abuse during puberty
Science and policy in substance abuse
Substance abuse treatment, prevention, and policy
Randomization in substance abuse clinical trials